Infectious diseases are illnesses caused by pathogenic microorganisms like bacteria, viruses, fungi, or parasites. These diseases can spread directly or indirectly from person to person, through contaminated food or water, insect bites, or airborne transmission. Common examples include influenza, tuberculosis, COVID-19, malaria, and HIV/AIDS.
On the other hand, non-infectious diseases are not caused by infectious agents and are typically not contagious. These conditions often arise due to genetic factors, lifestyle choices, environmental exposures, or a combination of these factors. Non-infectious diseases encompass a broad range of health issues such as cardiovascular diseases (like heart disease and stroke), cancer, diabetes, autoimmune disorders, allergies, mental health disorders, and chronic respiratory conditions like asthma.
While infectious diseases are characterized by the presence and spread of pathogens, non-infectious diseases primarily arise from internal dysfunctions, external factors, or a combination of both. Both types of diseases have significant impacts on individual health, public health, and healthcare systems, albeit through different mechanisms of origin and transmission.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States